vTv Therapeutics (VTVT) Long-Term Debt Issuances (2017)
vTv Therapeutics (VTVT) has disclosed Long-Term Debt Issuances for 3 consecutive years, with $7.5 million as the latest value for Q1 2017.
- Quarterly Long-Term Debt Issuances changed N/A to $7.5 million in Q1 2017 from the year-ago period, while the trailing twelve-month figure was $7.5 million through Dec 2019, changed 0.0% year-over-year, with the annual reading at $392000.0 for FY2025, N/A changed from the prior year.
- Long-Term Debt Issuances hit $7.5 million in Q1 2017 for vTv Therapeutics, up from $13000.0 in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $10.5 million in Q2 2015 to a low of $13000.0 in Q3 2015.
- Historically, Long-Term Debt Issuances has averaged $6.9 million across 3 years, with a median of $8.2 million in 2015.
- Biggest YoY gain for Long-Term Debt Issuances was 99.74% in 2015; the steepest drop was 99.74% in 2015.
- Year by year, Long-Term Debt Issuances stood at $9.7 million in 2014, then plummeted by 99.87% to $13000.0 in 2015, then skyrocketed by 57592.31% to $7.5 million in 2017.
- Business Quant data shows Long-Term Debt Issuances for VTVT at $7.5 million in Q1 2017, $13000.0 in Q3 2015, and $10.5 million in Q2 2015.